Pujhitha Ramesh

Dr. Pujhitha Ramesh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
MJMatthew Jorgensen
Matthew Jorgensen
PRPujhitha Ramesh
Pujhitha Ramesh
MTMiriam Toro
Miriam Toro
EEEmily Evans
Emily Evans
NMNicholas Moskwa
Nicholas Moskwa
Yubing XieYubing Xie
Yubing Xie
Understanding the different regulatory functions of epithelial and mesenchymal cell types in salivary gland development and cellular organization is essential for proper organoid formation and salivary gland tissue regeneration. Here, we demonstrate a biocompatible platform using pre-formed alginate hydrogel microtubes to facilitate direct epithelial–mesenchymal cell interaction for 3D salivary gland cell organization, which allows for monitoring cellular organization while providing a protective barrier from cell-cluster loss during medium changes. Using mouse salivary gland ductal epithelial SIMS cells as the epithelial model cell type and NIH 3T3 fibroblasts or primary E16 salivary mesenchyme cells as the stromal model cell types, self-organization from epithelial–mesenchymal interaction was examined. We observed that epithelial and mesenchymal cells undergo aggregation on day 1, cavitation by day 4, and generation of an EpCAM-expressing epithelial cell layer as early as day 7 of the co-culture in hydrogel microtubes, demonstrating the utility of hydrogel microtubes to facilitate heterotypic cell–cell interactions to form cavitated organoids. Thus, pre-formed alginate microtubes are a promising co-culture method for further understanding epithelial and mesenchymal interaction during tissue morphogenesis and for future practical applications in regenerative medicine.

17 May 2022 in Biofabrication
Verified
Journal Article
Closed access
PRPujhitha Ramesh
Pujhitha Ramesh
NMNicholas Moskwa
Nicholas Moskwa
ZHZachary Hanchon
Zachary Hanchon
AKAdam Koplas
Adam Koplas
DNDeirdre A Nelson
Deirdre A Nelson
Yubing XieYubing Xie
Yubing Xie
Scaffold-based regenerative strategies that emulate physical, biochemical, and mechanical properties of the native extracellular matrix (ECM) of the region of interest can influence cell growth and function. Existing ECM-mimicking scaffolds, including nanofiber (NF) mats, sponges, hydrogels, and NF-hydrogel composites are unable to simultaneously mimic typical composition, topography, pore size, porosity, and viscoelastic properties of healthy soft-tissue ECM. In this work, we used cryoelectrospinning to fabricate 3D porous scaffolds with minimal fibrous backbone, pore size and mechanical properties similar to soft-tissue connective tissue ECM. We used salivary glands as our soft tissue model and found the decellularized adult salivary gland (DSG) matrix to have a fibrous backbone, 10–30 μ m pores, 120 Pa indentation modulus, and ∼200 s relaxation half time. We used elastin and alginate as natural, compliant biomaterials and water as the solvent for cryoelectrospinning scaffolds to mimic the structure and viscoelasticity of the connective tissue ECM of the DSG. Process parameters were optimized to produce scaffolds with desirable topography and compliance similar to DSG, with a high yield of >100 scaffolds/run. Using water as solvent, rather than organic solvents, was critical to generate biocompatible scaffolds with desirable topography; further, it permitted a green chemistry fabrication process. Here, we demonstrate that cryoelectrospun scaffolds (CESs) support penetration of NIH 3T3 fibroblasts 250–450 µ m into the scaffold, cell survival, and maintenance of a stromal cell phenotype. Thus, we demonstrate that elastin-alginate CESs mimic many structural and functional properties of ECM and have potential for future use in regenerative medicine applications.

5 March 2024 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
SBSuzette Farber-Katz Brown
Suzette Farber-Katz Brown
HNHien Nguyen
Hien Nguyen
PMPhilip Mzyk
Philip Mzyk
MIMichael L. De Ieso
Michael L. De Ieso
AUAndrea M. Unser
Andrea M. Unser
WSW. Daniel Stamer
W. Daniel Stamer
Purpose: Loss-of-function variants in the ANGPTL7 gene are associated with protection from glaucoma and reduced intraocular pressure (IOP). We investigated the role of ANGPTL7 in IOP homeostasis and its potential as a target for glaucoma therapeutics. Methods: IOP, outflow facility, and outflow tissue morphology of Angptl7 knockout (KO) mice were assessed with and without dexamethasone (Dex). ANGPTL7 was quantified in conditioned media from human trabecular meshwork cells in response to Dex, in effluent from perfused human donor eyes, and in aqueous humor from human patients treated with steroids. Antibodies to ANGPTL7 were generated and tested in three-dimensional (3D) culture of outflow cells and perfused human donor eyes. Rabbits were injected intravitreally with a neutralizing antibody targeting ANGPTL7, and IOP was measured. Results: IOP was significantly elevated, but outflow facility and outflow tissue morphology were not different between Angptl7 KO mice and littermates. When challenged with Dex, IOP increased in wild-type but not Angptl7 KO mice. In human samples, increased ANGPTL7 was seen in the aqueous humor of patients treated with steroids, regardless of glaucoma status. Using 3D culture, recombinant ANGPTL7 decreased, and ANGPTL7-blocking antibodies increased hydraulic conductivity. Significantly, outflow facility increased in human eyes treated ex vivo with ANGPTL7-blocking antibodies, and IOP decreased for 21 days in rabbits after a single injection of blocking antibodies. Conclusions: Using multiple models, we have demonstrated that excess ANGPTL7 increases outflow resistance and IOP and that neutralizing ANGPTL7 has beneficial effects in both naïve and steroid-induced hypertensive eyes, thus motivating the development of ANGPTL7-targeting therapeutics for the treatment of glaucoma.

5 June 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PRPujhitha Ramesh
Pujhitha Ramesh
RPRafael Pena
Rafael Pena
JMJennifer M. Morrissey
Jennifer M. Morrissey
NMNicholas Moskwa
Nicholas Moskwa
KTKate Tubbesing
Kate Tubbesing
Yubing XieYubing Xie
Yubing Xie
Salivary gland fibrosis results in salivary hypofunction whose current treatments are palliative. Mesenchymal stem/stromal cells (MSCs) are anti-fibrotic and anti-inflammatory and provide a promising alternative to treat fibrosis, but face translational challenges due to poor tissue targeting and retention. Scaffolds could facilitate targeted MSC delivery and improve MSC retention. Here, we demonstrated the feasibility of using stromal extracellular matrix (ECM)-mimicking elastin-alginate cryoelectrospun scaffolds (CES) for MSC delivery. Using MSC-like primary embryonic salivary mesenchyme cells (SMSCs), we demonstrated that CES supported viable, healthy and non-fibrotic long-term stromal cell maintenance while suppressing the fibrotic phenotype in myofibroblasts. We established an in vitro fibrosis model by coculturing SMSCs and myofibroblasts on CES and validated that SMSCs on CES imparted anti-fibrotic effects on myofibroblasts; however, these effects were suppressed by TGF-β1. In vivo orthotopic implantation of CES and SMSC-CES constructs showed that CES were biocompatible, non-inflammatory, and non-fibrotic, however, they did not remediate fibrosis. Further, supplementation of anti-fibrotic FGF2 to the in vitro fibrosis model demonstrated partial rescue of the anti-fibrotic effects of SMSC-CES constructs on myofibroblasts stimulated by TGF-β1 signaling. These studies set the premise for multi-pronged therapeutic approaches and validate CES as a potential stromal cell delivery vehicle in regenerative medicine applications.

11 December 2025 in Gels
Verified
Journal Article
Open access
PDF file
PRPujhitha Ramesh
Pujhitha Ramesh
JCJames Castracane
James Castracane
MLMelinda Larsen
Melinda Larsen
DNDeirdre A. Nelson
Deirdre A. Nelson
Susan T. SharfsteinSusan T. Sharfstein
Susan T. Sharfstein
Yubing XieYubing Xie
Yubing Xie
Bioengineered functional salivary tissues can advance regenerative therapies, preclinical drug testing, and the fundamental understanding of salivary gland dysfunction. Current salivary tissue models are typically Matrigel-based, hydrogel-based or scaffold-free organoid systems, with limited physiological relevance or mimicry of cell-cell and cell-extracellular matrix (ECM) interactions. We previously developed elastin-alginate cryoelectrospun scaffolds (CES) that resemble the topography and viscoelastic properties of healthy salivary ECM, and validated their potential for stromal cell culture, delivery, and in vitro fibrosis modeling. Here, we evaluated the utility of CES to support 3D cocultures of salivary gland epithelial and mesenchymal cells in vitro. We compared CES with honeycomb-like topography (CES-H) to densely packed electrospun nanofibers (NFs) and CES with fibrous topography (CES-F) for their ability to support SIMS epithelial cell attachment, morphology, 3D clustering, phenotype and organization into distinct clusters when cocultured with stromal cells. Both CES-F and CES-H supported epithelial cell attachment and clustering; in particular, CES-H most effectively supported the self-organization of epithelial and stromal cells into distinct 3D clusters resembling the structure of native salivary tissue. Stromal cells were essential for maintaining the phenotype of epithelial cells cultured on CES-H, laying the foundation for the development of in vitro tissue models.

3 August 2025
Verified
Book Chapter
Closed access
KTKaren Y. Torrejon
Karen Y. Torrejon
AUAndrea M. Unser
Andrea M. Unser
PRPujhitha Ramesh
Pujhitha Ramesh
This chapter describes the protocols to bioengineer a 3D human trabecular meshwork tissue model using Glauconix Biosciences’ patented 3D-HTM™ system. These protocols combine species-relevant tissue with nanoengineering techniques in order to produce a 3D matrix to mimic the conventional outflow pathway, which is responsible for the majority of the aqueous humor drainage and intraocular pressure regulation in the eye. Currently, there is a lack of translation between glaucoma in the human eye and animal models, which fails to provide a sufficient platform for compound screening and intraocular pressure (IOP) assessment. To address this unmet need, a 3D-HTM™, which can be co-cultured with human Schlemm’s canal cells and induced to a glaucomatous-like state, was developed to provide a more applicable model for the evaluation of IOP-lowering therapeutics. The included protocols address the engineering of this 3D tissue model, as well as the examination of key biological markers of diseased tissue using traditional biological techniques with a few modifications. Additionally, a methodology for indirectly measuring IOP within the bioengineered 3D tissue is described. Overall, these protocols provide an in vitro alternative for studying glaucoma at the anterior segment, which can propel the development of glaucoma therapeutics.